علاج التهاب الأقنية الصفراوية الأولي في الحمل

References

DOI: 10.1002/hep.32117

• EASL recommends expert consultation for all pregnant patients to guide therapy, noting that pregnancy is typically well tolerated in non-cirrhotic patients with PBC.
• EASL recommends the continued use of UDCA in pregnancy, even though supporting data are limited.
• Pruritus management is important and may require specialist advice, noting that rifampicin has been used by experts during the third trimester (III, 1).
• Additionally, cholestyramine and rifampicin (third trimester onwards) are considered safe in pregnancy, although the data are limited.